NO822100L - Fremgangsmaate for fremstilling av terapeutisk aktive basiske acylamider av aminopyrazol-aryl-matanoner - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive basiske acylamider av aminopyrazol-aryl-matanonerInfo
- Publication number
- NO822100L NO822100L NO822100A NO822100A NO822100L NO 822100 L NO822100 L NO 822100L NO 822100 A NO822100 A NO 822100A NO 822100 A NO822100 A NO 822100A NO 822100 L NO822100 L NO 822100L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- dimethyl
- pyrazol
- hydrogen
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27757781A | 1981-06-26 | 1981-06-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO822100L true NO822100L (no) | 1982-12-27 |
Family
ID=23061477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO822100A NO822100L (no) | 1981-06-26 | 1982-06-23 | Fremgangsmaate for fremstilling av terapeutisk aktive basiske acylamider av aminopyrazol-aryl-matanoner |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0068806A3 (enExample) |
| JP (1) | JPS584771A (enExample) |
| AU (1) | AU8515182A (enExample) |
| DD (1) | DD202547A5 (enExample) |
| DK (1) | DK282882A (enExample) |
| ES (3) | ES8304550A1 (enExample) |
| FI (1) | FI822260A7 (enExample) |
| GR (1) | GR76155B (enExample) |
| IL (1) | IL66109A0 (enExample) |
| NO (1) | NO822100L (enExample) |
| ZA (1) | ZA824468B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ208555A (en) * | 1983-06-23 | 1987-06-30 | American Cyanamid Co | (3-amino-1h-pyrazol-4-yl)-arylmethanone derivatives |
| DE3600950A1 (de) * | 1986-01-15 | 1987-07-16 | Bayer Ag | 5-acylamido-1-aryl-pyrazole |
| FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| EP1934219A1 (en) | 2005-09-16 | 2008-06-25 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3558605A (en) * | 1969-05-14 | 1971-01-26 | Parke Davis & Co | Pyrazolo(3,4-e)(1,4)diazepin-7-(1h)-one compounds |
| BE735597A (en) * | 1969-07-03 | 1970-01-05 | 1-aryl 3 4-opt subst 5-aminoalkanoylamino-pyrazoles | |
| FR2100973A1 (en) * | 1970-07-30 | 1972-03-24 | Yoshitomi Pharmaceutical | 5-Aminopyrazoles - with analgesic, antiinflammatory and muscle relaxant activity |
| US3886143A (en) * | 1974-01-21 | 1975-05-27 | Parke Davis & Co | Oxazolo {8 3,2-D{9 pyrazolo{8 4,3-F{9 {0 {8 1,4{9 diazepin-6(7H)-one compounds |
-
1982
- 1982-06-23 ZA ZA824468A patent/ZA824468B/xx unknown
- 1982-06-23 FI FI822260A patent/FI822260A7/fi not_active Application Discontinuation
- 1982-06-23 ES ES513398A patent/ES8304550A1/es not_active Expired
- 1982-06-23 NO NO822100A patent/NO822100L/no unknown
- 1982-06-23 ES ES513399A patent/ES8304551A1/es not_active Expired
- 1982-06-23 AU AU85151/82A patent/AU8515182A/en not_active Abandoned
- 1982-06-23 GR GR68535A patent/GR76155B/el unknown
- 1982-06-23 ES ES513375A patent/ES8305350A1/es not_active Expired
- 1982-06-23 JP JP57106982A patent/JPS584771A/ja active Pending
- 1982-06-23 IL IL66109A patent/IL66109A0/xx unknown
- 1982-06-23 EP EP82303267A patent/EP0068806A3/en not_active Withdrawn
- 1982-06-23 DD DD82241009A patent/DD202547A5/de unknown
- 1982-06-23 DK DK282882A patent/DK282882A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES513399A0 (es) | 1983-03-01 |
| DD202547A5 (de) | 1983-09-21 |
| EP0068806A2 (en) | 1983-01-05 |
| ZA824468B (en) | 1983-04-27 |
| ES513398A0 (es) | 1983-03-01 |
| ES8304550A1 (es) | 1983-03-01 |
| IL66109A0 (en) | 1982-09-30 |
| GR76155B (enExample) | 1984-08-03 |
| FI822260A0 (fi) | 1982-06-23 |
| JPS584771A (ja) | 1983-01-11 |
| FI822260L (fi) | 1982-12-27 |
| EP0068806A3 (en) | 1983-08-10 |
| ES513375A0 (es) | 1983-04-01 |
| ES8305350A1 (es) | 1983-04-01 |
| FI822260A7 (fi) | 1982-12-27 |
| ES8304551A1 (es) | 1983-03-01 |
| DK282882A (da) | 1982-12-27 |
| AU8515182A (en) | 1983-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI242004B (en) | 1-(1-substituted-4-piperidinyl)methyl-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds | |
| US5618833A (en) | 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present | |
| US5017596A (en) | Arylpyrazolylcarbinol compounds with analgesic activity | |
| HUP0104280A2 (hu) | Dopamin D3 receptorok modulátoraiként felhasználható tetrahidrobenzazepin-származékok, eljárás az előállításukra, a vegyületeket tartalmazó gyógyszerkészítmények | |
| CN101001850A (zh) | 酰胺基化合物及其作为药物的应用 | |
| CA2621255A1 (en) | Amido compounds and their use as pharmaceuticals | |
| AU4059993A (en) | 1-piperazino-1,2-dihydroindene derivatives | |
| WO1997008167A1 (en) | 5ht2c and 5ht2b antagonists | |
| IL99452A (en) | Aryl fused and hetaryl fused 2,4-diazepines and 2,4-diazocines their preparation and pharmaceutical compositions containing them | |
| US7271168B2 (en) | Piperazine derivatives having SST1 antagonistic activity | |
| NO311515B1 (no) | Tetrahydrobenzindolforbindelser, og farmasöytiske preparater inneholdende slike forbindelser | |
| DK157864B (da) | Hidtil ukendte 1-piperazincarboxamidderivater substitueret paa det basiske nitrogenatom samt farmaceutiske praeparater og sammensaetninger indeholdende disse | |
| Peglion et al. | Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines | |
| US4727072A (en) | 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents | |
| US5834482A (en) | Heterocyclic chemistry | |
| EP2280940A1 (en) | Novel n-(2-amino-phenyl)-acrylamides | |
| NO822100L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive basiske acylamider av aminopyrazol-aryl-matanoner | |
| US4677104A (en) | Antipsychotic fused-ring pyridinylpiperazine derivatives | |
| US4515944A (en) | 1,5-Diphenyl-2-haloalkylpyrazolin-3-one intermediates | |
| CA2900629C (en) | Pyrazolylbenzo[d]imidazole derivatives | |
| US4758563A (en) | 3-alkoxy-2-aminopropyamines, cardiovascular compositions and use | |
| CA2571555A1 (en) | Diazabicyclic histamine-3 receptor antagonists | |
| AU704728B2 (en) | 1-{omega-(3,4-dihydro-2-naphthalenyl)alkyl} cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same | |
| NZ248414A (en) | Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents | |
| NO862494L (no) | Fremgangsmaate for fremstilling av nye aromatiske forbindelser. |